Medicinal composition for treating cerebral infarction
A composition and drug technology, applied in the field of medicine, can solve the problems of prevention and/or treatment of cerebral infarction that have not been found
Active Publication Date: 2013-08-14
TIANJIN HONGRENTANG PHARM CO LTD
View PDF6 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0007] After reviewing the literature, no report was found on the combination of Gastrodia elata and Rhodiola rosea for the prevention and / or treatment of cerebral infarction
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0045] 10 parts by weight of gastrodia elata and 10 parts by weight of rhodiola rosea are used as raw materials to prepare pharmaceutical preparations.
Embodiment 2
[0047] 9 parts by weight of Gastrodia elata, 12 parts by weight of Rhodiola rosea, 8 parts by weight of Uncaria vine, and 4 parts by weight of polygala, and the above drugs are used as raw materials to prepare a pharmaceutical preparation.
Embodiment 3
[0049] 3 parts by weight of Gastrodia elata, 3 parts by weight of Rhodiola rosea, 2 parts by weight of Panax notoginseng, 2 parts by weight of fritillary fritillaria, and the above drugs are used as raw materials to prepare a pharmaceutical preparation.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a medicinal composition for preventing and / or treating cerebral infarction. The medicinal composition is characterized by comprising tall gastrodia tuber and rhodiola rosea serving as monarch drugs, one or two of uncaria and pseudo-ginseng serving as ministerial drugs, as well as one or more of hemlock parsley, thunberg fritillary bulb and thinleaf milkwort root bark serving as adjuvant drugs. Pharmacological tests prove that: compared with the conventional preparation, the medicinal composition disclosed by the invention has better pharmacological effects in preventing and / or treating cerebral infarction.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for preventing and / or treating cerebral infarction, wherein the monarch drugs in the pharmaceutical composition are Gastrodia elata and Rhodiola rosea. Background technique [0002] Cerebral infarction (Cerebral Infarction, CI), also known as ischemic stroke, refers to ischemic necrosis or encephalomalacia of localized brain tissue caused by cerebral blood supply disturbance, ischemia and hypoxia, including cerebral thrombosis (arterial sclerotic cerebral infarction), lacunar infarction and cerebral embolism. The main clinical manifestations are hemiplegia, hemisensory disturbance, aphasia, hemianopia, ataxia and other focal neurological deficits. Cerebrovascular disease is a common and frequently-occurring disease in the elderly, and one of the three major diseases that threaten human health. It has the characteristics of high morbidity, high morta...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8988A61P9/10
Inventor 朱晓晶李凤阁杨欣莹
Owner TIANJIN HONGRENTANG PHARM CO LTD